73 related articles for article (PubMed ID: 34943502)
1. Expression of vascular endothelial growth factor receptor in thymic epithelial tumors.
Chiba K; Murase T; Yokota K; Tatematsu T; Oda R; Nakamura R; Yobita S; Takano T; Okuda K
Oncol Lett; 2024 Aug; 28(2):383. PubMed ID: 38939624
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.
Chatzikalil E; Stergiou IE; Papadakos SP; Konstantinidis I; Theocharis S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612645
[TBL] [Abstract][Full Text] [Related]
3. EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets.
Stergiou IE; Papadakos SP; Karyda A; Tsitsilonis OE; Dimopoulos MA; Theocharis S
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568780
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications.
Papadakos SP; Stergiou IE; Gkolemi N; Arvanitakis K; Theocharis S
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444544
[TBL] [Abstract][Full Text] [Related]
5. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
6. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
[TBL] [Abstract][Full Text] [Related]
7. EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia.
Pergaris A; Danas E; Gajdzis P; Levidou G; Gajdzis M; Cassoux N; Gardrat S; Donizy P; Korkolopoulou P; Kavantzas N; Klijanienko J; Theocharis S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626181
[TBL] [Abstract][Full Text] [Related]
8. Thymic Epithelial Tumors: An Evolving Field.
Kuhn E; Pescia C; Mendogni P; Nosotti M; Ferrero S
Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836670
[TBL] [Abstract][Full Text] [Related]
9. The role of Eph receptors and ephrin ligands in colorectal cancer.
Herath NI; Boyd AW
Int J Cancer; 2010 May; 126(9):2003-11. PubMed ID: 20039322
[TBL] [Abstract][Full Text] [Related]
10. Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches.
Masaoutis C; Georgantzoglou N; Sarantis P; Theochari I; Tsoukalas N; Bobos M; Alexandrou P; Pergaris A; Rontogianni D; Theocharis S
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943502
[TBL] [Abstract][Full Text] [Related]
11. Methylmercury alters Eph and ephrin expression during neuronal differentiation of P19 embryonal carcinoma cells.
Wilson DT; Polunas MA; Zhou R; Halladay AK; Lowndes HE; Reuhl KR
Neurotoxicology; 2005 Aug; 26(4):661-74. PubMed ID: 15990172
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
13. Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors.
Palamaris K; Levidou G; Kordali K; Masaoutis C; Rontogianni D; Theocharis S
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509515
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.
Sun TY; Nguyen B; Chen SB; Natkunam Y; Padda S; van de Rijn M; West R; Neal JW; Wakelee H; Riess JW
JTO Clin Res Rep; 2023 Apr; 4(4):100498. PubMed ID: 37020927
[TBL] [Abstract][Full Text] [Related]
15. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Tsoukalas N; Bournakis E; Alexandrou P; Kavantzas N; Patsouris E; Theocharis S
BMC Clin Pathol; 2014 Feb; 14(1):8. PubMed ID: 24495444
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
